Influence of Intravenous Epoprostenol on the Transpulmonary Gradient of Vascular Endothelial Growth Factor (VEGF) in Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Selimovic, N. [1 ]
Bergh, C-H. [1 ]
Andersson, B. [1 ]
Sakiniene, E. [1 ]
Carlsten, H. [1 ]
Rundqvist, B. [1 ]
机构：
[1] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2009年 / 28卷 / 02期
关键词：
D O I：
10.1016/j.healun.2008.11.716
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
709
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 50 条
  • [1] Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol
    Demerouti, Eftychia
    Karyofyllis, Panagiotis
    Manginas, Athanassios
    Anthi, Anastasia
    Karatasakis, George
    Athanassopoulos, George
    Voudris, Vassilios
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (02) : 99 - 105
  • [2] Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol
    Eftychia Demerouti
    Panagiotis Karyofyllis
    Athanassios Manginas
    Anastasia Anthi
    George Karatasakis
    George Athanassopoulos
    Vassilios Voudris
    American Journal of Cardiovascular Drugs, 2019, 19 : 99 - 105
  • [3] Vascular endothelial growth factor (VEGF) as marker of pulmonary hypertension in children with asthma
    Lebedenko, Alexander
    Semernik, Olga
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension
    Sitbon, Olivier
    Manes, Alessandra
    Jais, Xavier
    Pallazini, Massimiliano
    Humbert, Marc
    Presotto, Luis
    de Nillette, Louis
    Zaccardelli, Divid
    Davis, Gillian
    Jeff, Roger
    Simonneau, Gerald
    Galie, Naareno
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) : 1 - 5
  • [5] The Role of Vascular Endothelial Growth Factor in Pulmonary Arterial Hypertension The Angiogenesis Paradox
    Voelkel, Norbert F.
    Gomez-Arroyo, Jose
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2014, 51 (04) : 474 - 484
  • [6] Vascular endothelial growth factor in pulmonary hypertension
    Voelkel, NF
    Hoeper, M
    Maloney, J
    Tuder, RM
    CYTOKINES AND ADHESION MOLECULES IN LUNG INFLAMMATION, 1996, 796 : 186 - 193
  • [7] Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil
    Ivy, D. Dunbar
    Claussen, Lori
    Doran, Aimee
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05): : 696 - 698
  • [8] VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) INDUCTION IN PRIMARY PULMONARY-HYPERTENSION
    TUDER, R
    VOELKEL, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 330 - 330
  • [9] Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
    Timofeev, Julia
    Ruiz, George
    Fries, Melissa
    Driggers, Rita W.
    AJP REPORTS, 2013, 3 (02): : 71 - 74
  • [10] Intravenous epoprostenol therapy in the treatment of pulmonary arterial hypertension in Singapore
    Choo, Jack
    Yap, Jonathan
    Ismail, Aidila
    Hon, Jin Shing
    Ruan, Wen
    Low, Andrea
    Lim, Soo Teik
    Tan, Ju Le
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2024, 53 (10) : 627 - 631
12345